Back to homepage

Posts From Sophia Zhao

08/03 News Flash 1: COVID-19 Vaccine Design Using a Machine Learning Model

08/03 News Flash 1: COVID-19 Vaccine Design Using a Machine Learning Model

Image courtesy of Flickr. Researchers from Massachusetts Institute of Technology (MIT) have recently developed a machine learning method called OptiVax to evaluate the effectiveness of potential SARS-CoV-2 peptide vaccines. Such vaccines contain peptides, or short protein segments, that prime the

07/08 News Flash 1: Repurposing existing anticancer drugs to combat SARS-COV-2

07/08 News Flash 1: Repurposing existing anticancer drugs to combat SARS-COV-2

Image courtesy of Flickr. As no treatment has been shown to effectively combat the SARS-COV-2 virus yet, looking towards existing drugs may hasten this identification process. A cohort of researchers suggest repurposing anticancer drugs— COVID-19 and cancer both share pathophysiological

06/15 News Flash 3: Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study

06/15 News Flash 3: Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study

Image courtesy of Pikist. Researchers based in Northern Italy recently took towards analyzing pathological features of infected lung tissue samples of thirty-eight deceased patients to better understand the pathogenesis and clinical manifestations of COVID-19. The team of scientists observed that

06/08 News Flash 2: Remdesivir, an antiviral, shows some benefit against COVID-19 in rhesus macaques

06/08 News Flash 2: Remdesivir, an antiviral, shows some benefit against COVID-19 in rhesus macaques

Image courtesy of Pixabay. Joining the race to discover an effective COVID-19 treatment, researchers are now looking towards investigating remdesivir, a broad-spectrum antiviral medication.  In particular, a cohort of scientists tested remdesivir in a rhesus macaque (primate) model to determine

Targeting the Mitochondria: Articulating Safety to Combat Liver Disease

Targeting the Mitochondria: Articulating Safety to Combat Liver Disease

Nonalcoholic fatty liver disease (NAFLD), which afflicts up to one-third of the general adult population, is swiftly becoming the most common cause of chronic liver disease. NAFLD is also associated with type 2 diabetes and cardiovascular disease. In a Yale-spearheaded